OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
Daniele Fanale, Alessia Pivetti, D. Cancelliere, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103626-103626
Closed Access | Times Cited: 14
Daniele Fanale, Alessia Pivetti, D. Cancelliere, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103626-103626
Closed Access | Times Cited: 14
Showing 14 citing articles:
Hereditary Gynecologic Cancer Syndromes – A Narrative Review
Stoyan Kostov, Rafał Watrowski, Yavor Kornovski, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 381-405
Open Access | Times Cited: 20
Stoyan Kostov, Rafał Watrowski, Yavor Kornovski, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 381-405
Open Access | Times Cited: 20
Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomes
Juhyeong Kim, Mi‐Ae Jang, Jong Eun Park, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e093905-e093905
Open Access
Juhyeong Kim, Mi‐Ae Jang, Jong Eun Park, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e093905-e093905
Open Access
Anticipation effect in Pakistani breast cancer families with or without BRCA1/2 pathogenic variants
Noor Muhammad, Humaira Naeemi, Shumaila Arif, et al.
Cancer Epidemiology (2025) Vol. 96, pp. 102782-102782
Closed Access
Noor Muhammad, Humaira Naeemi, Shumaila Arif, et al.
Cancer Epidemiology (2025) Vol. 96, pp. 102782-102782
Closed Access
BRCA2 prevents PARPi-mediated PARP1 retention to protect RAD51 filaments
Sudipta Lahiri, George L. Hamilton, Gemma Moore, et al.
Nature (2025)
Closed Access
Sudipta Lahiri, George L. Hamilton, Gemma Moore, et al.
Nature (2025)
Closed Access
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation
Piera Grisolia, Rossella Tufano, Clara Iannarone, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Piera Grisolia, Rossella Tufano, Clara Iannarone, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
Daniele Fanale, Lidia Rita Corsini, Erika Pedone, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 190, pp. 104086-104086
Open Access | Times Cited: 3
Daniele Fanale, Lidia Rita Corsini, Erika Pedone, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 190, pp. 104086-104086
Open Access | Times Cited: 3
Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond
Hayley L. Rein, Kara A. Bernstein
DNA repair (2023) Vol. 130, pp. 103563-103563
Closed Access | Times Cited: 2
Hayley L. Rein, Kara A. Bernstein
DNA repair (2023) Vol. 130, pp. 103563-103563
Closed Access | Times Cited: 2
Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from “Uncertain Significance” to “Pathogenic” based on minigene assays and clinical evidence
Ying Ning, Yu Zhang, Tian Tian, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access
Ying Ning, Yu Zhang, Tian Tian, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access
The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population
Masashi Idogawa, Tasuku Mariya, Yumi Tanaka, et al.
Journal of Human Genetics (2024) Vol. 69, Iss. 5, pp. 225-230
Open Access
Masashi Idogawa, Tasuku Mariya, Yumi Tanaka, et al.
Journal of Human Genetics (2024) Vol. 69, Iss. 5, pp. 225-230
Open Access
Medicolegal and insurance issues regardingBRCA1andBRCA2gene tests in high income countries
Riccardo Oliva, Simone Grassi, Cláudia Marchetti, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 6, pp. 935-941
Closed Access
Riccardo Oliva, Simone Grassi, Cláudia Marchetti, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 6, pp. 935-941
Closed Access
Analyzing the mutational landscape of prostate cancer susceptibility genes through next-generation sequencing (NGS)
Farwa Riaz, Sabira Sultana, L.M.B.O. Asad, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 9, pp. 4450-4465
Closed Access
Farwa Riaz, Sabira Sultana, L.M.B.O. Asad, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 9, pp. 4450-4465
Closed Access
Proline variants in the BRCA1 coiled‐coil domain disrupt folding and binding to PALB2
C. B. Baker, Precious Grace C. Pajela, Davis E. Martin, et al.
Protein Science (2024) Vol. 34, Iss. 1
Open Access
C. B. Baker, Precious Grace C. Pajela, Davis E. Martin, et al.
Protein Science (2024) Vol. 34, Iss. 1
Open Access
Heterogeneities in Hereditary Cancer Genes as Revealed by a Large-Scale Genome Analysis
Yukihide Momozawa
(2023), pp. 59-78
Closed Access
Yukihide Momozawa
(2023), pp. 59-78
Closed Access
